Research ArticleCARDIOVASCULAR
Pharmacological Effects of ATI22-107 [2-(2-{2-[2-Chloro-4-(6-oxo-1,4,5,6-tetrahydro-pyridazin-3-yl)-phenoxy]-acetylamino}-ethoxymethyl)-4-(2-chloro-phenyl)-6-methyl-1,4-dihydro-pyridine-3,5-dicarboxylic Acid Dimethyl Ester)], a Novel Dual Pharmacophore, on Myocyte Calcium Cycling and Contractility
Albert S. Jung, Michael P. Quaile, Geoffrey D. Mills, Daniel P. Bednarik, Steven R. Houser and Kenneth B. Margulies
Journal of Pharmacology and Experimental Therapeutics February 2005, 312 (2) 517-524; DOI: https://doi.org/10.1124/jpet.104.075895
Albert S. Jung
Departments of Physiology and Cardiology, Temple University, Philadelphia, Pennsylvania (A.S.J., M.P.Q., G.D.M., S.R.H., K.B.M.); and Department of Cardiovascular Biology, Artesian Therapeutics Inc., Gaithersburg, Maryland (D.P.B.)
Michael P. Quaile
Departments of Physiology and Cardiology, Temple University, Philadelphia, Pennsylvania (A.S.J., M.P.Q., G.D.M., S.R.H., K.B.M.); and Department of Cardiovascular Biology, Artesian Therapeutics Inc., Gaithersburg, Maryland (D.P.B.)
Geoffrey D. Mills
Departments of Physiology and Cardiology, Temple University, Philadelphia, Pennsylvania (A.S.J., M.P.Q., G.D.M., S.R.H., K.B.M.); and Department of Cardiovascular Biology, Artesian Therapeutics Inc., Gaithersburg, Maryland (D.P.B.)
Daniel P. Bednarik
Departments of Physiology and Cardiology, Temple University, Philadelphia, Pennsylvania (A.S.J., M.P.Q., G.D.M., S.R.H., K.B.M.); and Department of Cardiovascular Biology, Artesian Therapeutics Inc., Gaithersburg, Maryland (D.P.B.)
Steven R. Houser
Departments of Physiology and Cardiology, Temple University, Philadelphia, Pennsylvania (A.S.J., M.P.Q., G.D.M., S.R.H., K.B.M.); and Department of Cardiovascular Biology, Artesian Therapeutics Inc., Gaithersburg, Maryland (D.P.B.)
Kenneth B. Margulies
Departments of Physiology and Cardiology, Temple University, Philadelphia, Pennsylvania (A.S.J., M.P.Q., G.D.M., S.R.H., K.B.M.); and Department of Cardiovascular Biology, Artesian Therapeutics Inc., Gaithersburg, Maryland (D.P.B.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleCARDIOVASCULAR
Pharmacological Effects of ATI22-107 [2-(2-{2-[2-Chloro-4-(6-oxo-1,4,5,6-tetrahydro-pyridazin-3-yl)-phenoxy]-acetylamino}-ethoxymethyl)-4-(2-chloro-phenyl)-6-methyl-1,4-dihydro-pyridine-3,5-dicarboxylic Acid Dimethyl Ester)], a Novel Dual Pharmacophore, on Myocyte Calcium Cycling and Contractility
Albert S. Jung, Michael P. Quaile, Geoffrey D. Mills, Daniel P. Bednarik, Steven R. Houser and Kenneth B. Margulies
Journal of Pharmacology and Experimental Therapeutics February 1, 2005, 312 (2) 517-524; DOI: https://doi.org/10.1124/jpet.104.075895
Research ArticleCARDIOVASCULAR
Pharmacological Effects of ATI22-107 [2-(2-{2-[2-Chloro-4-(6-oxo-1,4,5,6-tetrahydro-pyridazin-3-yl)-phenoxy]-acetylamino}-ethoxymethyl)-4-(2-chloro-phenyl)-6-methyl-1,4-dihydro-pyridine-3,5-dicarboxylic Acid Dimethyl Ester)], a Novel Dual Pharmacophore, on Myocyte Calcium Cycling and Contractility
Albert S. Jung, Michael P. Quaile, Geoffrey D. Mills, Daniel P. Bednarik, Steven R. Houser and Kenneth B. Margulies
Journal of Pharmacology and Experimental Therapeutics February 1, 2005, 312 (2) 517-524; DOI: https://doi.org/10.1124/jpet.104.075895
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement